F. de Blay
French Institute of Health and Medical Research
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by F. de Blay.
Clinical & Experimental Allergy | 2001
F. de Blay; Catherine Duvernelle; Caroline Olgart; Dominique Israel-Biet; P. Krieger; Lionel Moreau; C. P. Muller; Gabrielle Pauli; Nelly Frossard
Background Repeated inhalation of allergen at low‐dose induces an increase in bronchial hyper‐responsiveness, without any associated symptom. The concomitant events in the bronchus have not been described.
European Respiratory Journal | 2002
C. Olgart Höglund; F. de Blay; J-P. Oster; Catherine Duvernelle; G. Pauli; Nelly Frossard
Nerve growth factor (NGF) has recently been suggested to be an important mediator of inflammation. In support of this, serum levels of NGF have been shown to be enhanced in asthmatics. However, it has not yet been shown whether the levels of NGF are also altered locally in asthmatic airways, when compared with healthy subjects, and the localisation of potential sources of NGF in the human bronchus have not yet been described. The aim of the present study was to assess NGF levels in bronchoalveolar lavage fluid (BALF) from asthmatics and to compare them to those of control subjects. Furthermore, the authors wanted to localise potential sources of NGF in bronchial tissue, and to number NGF-immunopositive infiltrating cells in the bronchial submucosa. BALF and bronchial biopsies were obtained from seven control subjects and seven asthmatic patients by fibreoptic bronchoscopy. NGF protein levels were quantified by enzyme-linked immunosorbent assay in BALF. NGF localisation was examined by immunohistochemistry on bronchial biopsy sections. The asthmatics exhibited significantly enhanced NGF levels in BALF. Intense NGF-immunoreactivity was observed in bronchial epithelium, smooth muscle cells and infiltrating inflammatory cells in the submucosa, and to a lesser extent in the connective tissue. The asthmatics exhibited a higher number of NGF-immunoreactive infiltrating cells in the bronchial submucosa than control subjects. This study provides evidence that nerve growth factor is locally produced in the airways, and shows that this production is enhanced in asthmatics. These findings suggest that nerve growth factor is produced by both structural cells and infiltrating inflammatory cells in human bronchus in vivo, and the authors suggest that the increase in nerve growth factor protein in bronchoalveolar lavage fluid observed in asthmatic patients may originate both from structural cells, producing increased nerve growth factor levels in inflammatory conditons, and from the increase in nerve growth factor-immunopositive cells determined in the bronchial submucosa.
Allergy | 2006
A. Casset; C. Marchand; Ashok Purohit; S. Le Calvé; Béatrice Uring-Lambert; C. Donnay; P. Meyer; F. de Blay
Background: Formaldehyde, an indoor air pollutant, is known to be an irritant and an etiologic factor in occupational asthma. An epidemiologic study suggests that it may also increase the risk of childhood asthma for concentrations above 60 μg/m3.
Clinical & Experimental Allergy | 2004
Carine Delayre-Orthez; F. de Blay; Nelly Frossard; FrEdEric Pons
Background Levels of endotoxins greatly differ according to environmental settings.
Clinical & Experimental Allergy | 2013
A. Kuehn; Christiane Hilger; C. Lehners-Weber; F. Codreanu-Morel; M. Morisset; C. Metz-Favre; Guido F. Pauli; F. de Blay; D. Revets; C. P. Muller; Lothar Vogel; S. Vieths; François Hentges
The majority of fish‐allergic patients are sensitized to parvalbumin, known to be the cause of important IgE cross‐reactivity among fish species. Little is known about the importance of fish allergens other than parvalbumin.
Allergy | 2013
V. van Kampen; F. de Blay; Ilenia Folletti; P. Kobierski; Gianna Moscato; M. Olivieri; Santiago Quirce; J. Sastre; Jolanta Walusiak-Skorupa; Monika Raulf-Heimsoth
Skin prick testing (SPT) in combination with the clinical history of the patient is one important step in the diagnosis of IgE‐mediated occupational allergies. However, skin test performance is related to the quality of allergen extracts. The present consensus document was prepared by an EAACI Task Force consisting of an expert panel of allergologists and occupational physicians from Germany, Italy, Spain, France, Austria, and Poland. All members of the panel were also involved in the data collection within the European multicentre study STADOCA (Standard diagnosis for occupational allergy). The aim of this Task Force was the assessment of the quality of commercially available SPT solutions for selected occupational allergens under standardized procedure conditions in different European centres and institutes of Occupational Medicine. The data evaluation shows a wide variability among SPT solutions and also indicates that the sensitivity of several SPT solutions is low. Therefore, improvement and standardization of SPT solutions for occupational allergens is highly recommended. Clinical practitioners should also not presume that their SPT solutions are fully reliable. The main objective of the document is to issue consensus suggestions for the use of SPT with occupational allergens based on the European multicentre study STADOCA, on existing scientific evidence and the expertise of a panel of allergologists.
Allergy | 2010
Z. A. Randriamanantany; I. Annesi-Maesano; D. Moreau; C. Raherison; D. Charpin; F. Lavaud; A. Taytard; F. de Blay; D. Caillaud
To cite this article: Randriamanantany ZA, Annesi‐Maesano I, Moreau D, Raherison C, Charpin D, Kopferschmitt C, Lavaud F, Taytard A, De Blay F, Caillaud D. Alternaria sensitization and allergic rhinitis with or without asthma in the French Six Cities study. Allergy 2010; 65: 368–375.
Allergy | 2013
V. van Kampen; F. de Blay; Ilenia Folletti; P. Kobierski; Gianna Moscato; M. Olivieri; Santiago Quirce; J. Sastre; Jolanta Walusiak-Skorupa; N. Kotschy-Lang; H. Müsken; V. Mahler; S. Schliemann; U. Ochmann; J. Sültz; M. Worm; I. Sander; Eva Zahradnik; Thomas Brüning; R. Merget; Monika Raulf-Heimsoth
Skin prick testing (SPT) is an important step in the diagnosis of IgE‐mediated occupational allergic diseases. The outcome of SPT is related to the quality of allergen extracts. Thus, the aim of the study was to assess different commercially available SPT solutions for selected occupational allergens.
Clinical & Experimental Allergy | 2002
F. Lieutier-Colas; P. Meyer; FrEdEric Pons; Guy Hédelin; P. Larsson; P. Malmberg; Gabrielle Pauli; F. de Blay
Objective To analyse the relation between airborne exposure to major rat allergen and to endotoxins in exclusively rat‐exposed workers and the prevalence of rat‐related symptoms and sensitization.
Clinical & Experimental Allergy | 2014
Maria Gonzalez; J. Jégu; M.-C. Kopferschmitt; C. Donnay; Guy Hédelin; F. Matzinger; Michel Velten; L. Guilloux; Alain Cantineau; F. de Blay
An increased incidence of asthma has been reported among healthcare workers. The role of quaternary ammonium compounds (QACs), commonly used in cleaning/disinfection products, has not been clearly defined. The aim of this study was to analyse associations between asthma and occupational exposure to disinfectants, especially QACs.